N-Acetylprocainamide anosyl(1→3)]-β-D-glucopyranosyl 28-O-β-D-glucuronopyranoside Antidotes for Novel Oral Anticoagulants:

Antidotes for Novel Oral Anticoagulants: Current Status and Future Potential

dBET6 is well tolerated

Citalopram（25-150 μM) shows a concentration-dependent cytotoxicity on the viability of rat B104

ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase

1) and 5-HT-evoked increases in intracellular calcium (pIC50 = 10

N-Acetylprocainamide anosyl(1→3)]-β-D-glucopyranosyl 28-O-β-D-glucuronopyranoside Antidotes for Novel Oral Anticoagulants:N Acetylprocainamide is a class III antiarrhythmic, which blocks K+ channels. Product information CAS Number: 32795 44 1 Molecular Weight: 277. 36 Formula: C15H23N3O2 Chemical Name: N [2 (diethylamino)ethyl] 4 acetamidobenzamide Smiles: CC(=O)NC1C=CC(=CC=1)C(=O)NCCN(CC)CC InChiKey: KEECCEWTUVWFCV UHFFFAOYSA N InChi: InChI=1S C15H23N3O2 c1 4 18(5 2)11 10 16 15(20)13 6 8 14(9 7 13)17 12(3)19 h6 9H,4 5,10 11H2,1 3H3,(H,16,20)(H,17,19) Technical Data